Abstract
As the introduction for the discussion on generic drugs, I explain the definition of generic drugs in the regulation, data required for NDA of generic drugs, their price in the National Health Insurance Scheme, generic drugs in the National Health Insurance Scheme, the criticism on generic drugs, patents and generic drugs and the market share of generic drugs in Japan, And I also explain circumstances of generic drugs in the United States of America.
